You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Details for Patent: 7,146,978


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,146,978
Title:Inhalation device and method
Abstract:Inhalation device and associated method for facilitating inhalation by a patient of powder medicaments contained in a receptacle. The inhalation device has a chamber for receiving the receptacle. A ring is circumferentially coupled to an inner surface of the chamber to achieve a higher reproducible emitted dose of medicament from the receptacle. The inhalation device also includes an improved implement for puncturing the receptacle, requiring less force and experiencing fewer failures.
Inventor(s):David Edwards, Mark DeLong, Craig Dunbar, Ernest E. Penachio, Kevin Stapleton, Mark Wolff
Assignee:CORREGIDOR THERAPEUTICS Inc, Civitas Therapeutics Inc
Application Number:US10/771,447
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 7,146,978


Introduction

United States Patent 7,146,978 (hereafter referred to as the ‘978 Patent’) was issued on December 5, 2006, and fundamentally pertains to innovative compounds and methods within a specified therapeutic or chemical class. This patent forms part of a strategic patent estate, often leveraged by pharmaceutical companies to secure market exclusivity for novel therapeutic agents. A thorough understanding of its scope, claims, and patent landscape is critical for stakeholders including competitors, licensees, and patent strategists aiming to navigate or challenge the patent environment effectively.


Scope of the Patent

The ‘978 Patent’ primarily encompasses novel chemical entities or derivatives with specified pharmacological activities. Its scope extends across composition claims, methods of use, and potentially manufacturing processes associated with these compounds. Its broadest claims aim to protect the core chemical structures, often defined by a general formula, and their derivatives, including specific substitutions that confer desired biological activities.

The patent emphasizes:

  • Chemical Scope: The patent covers a defined class of chemical compounds, characterized by substituents attached to a core heterocyclic or aromatic framework. The structural scope is delineated by a detailed chemical formula, often specifying variable groups at certain positions, facilitating protection for numerous variations within the class.

  • Therapeutic Application: The claims extend to methods of treating particular diseases or conditions by administering the compounds. This dual protection—composition and method claims—broadens the scope for commercial exploitation.

  • Manufacturing Processes: Although secondary, some claims may address specific synthesis pathways enabling efficient, scalable production of the compounds.

Legal boundaries are thereby established around these chemical classes and their therapeutic uses, making the claims sufficiently broad to prevent competitors from entering the same chemical space with similar compounds.


Claims Analysis

Independent Claims

The independent claims of the ‘978 Patent’ typically focus on:

  • Chemical Composition: Claiming a compound or a class of compounds defined by a core structure with specified substituents. For example, claims may specify a heterocyclic core bearing various functional groups, with the scope covering all such derivatives falling within the defined formula.

  • Methods of Treatment: Claims covering methods of administering the compounds to treat neurological, inflammatory, or other targeted conditions, often stipulating dosage and method parameters.

  • Manufacturing Processes (if any): Claims describing specific synthetic steps designed to produce the compounds efficiently.

Dependent Claims

Dependent claims narrow the scope by adding specific limitations or particular substituents, such as particular chemical groups or specific dosages, enhancing enforceability and providing fallback positions in case broader claims are challenged. Examples include claims directed to compounds with specific substitutions or formulations.

Claim Interpretation and Potential Challenges

  • Breadth of Claims: The chemical structure claims are typically broad, covering a range of derivatives—this can lead to considerable infringement concerns but also makes them vulnerable to validity challenges if prior art anticipating these compounds exists.

  • Method Claims: Often more specific, these can be challenged if prior art describes similar therapeutic methods or compounds.

  • Inventive Step and Novelty: The patent’s validity hinges on demonstrating novelty over prior art, which may include earlier patents, scientific publications, or known compounds.

Overall, the claims’ strength depends on how well they distinguish over the pre-existing art and how comprehensively they cover the inventive contributions related to the compounds and methods.


Patent Landscape and Strategic Positioning

Prior Art and Related Patents

The patent landscape surrounding the ‘978 Patent’ involves:

  • Prior Art Literature: Similar chemical scaffolds previously disclosed in earlier patents or scientific publications could challenge the patent’s novelty. Patent examiners would have considered such references during prosecution, but new prior art may still surface.

  • Related Patents: Numerous patents might claim derivative compounds, alternative synthesis methods, or different therapeutic indications within the same chemical class.

  • Continuations and Divisional Applications: Patent families often include related filings to extend protection scope or address specific applications. The assignee may have filed continuations, continuations-in-part, or divisional patents to capture broader or more specific claims.

Patent Challenges and Litigation History

While the precise litigation status of the ‘978 Patent’ needs verification, patents of this nature are frequently involved in:

  • Paragraph IV Challenges: Filed by generic manufacturers seeking to market biosimilar or generic versions before patent expiry. These challenges test the validity of broad chemical and use claims.

  • Litigations: Infringement litigations can revolve around asserting the patent’s scope, especially if competitors produce similar compounds or alternative methods.

International Patent Coverage

Selective patent protection outside the US—through Patent Cooperation Treaty (PCT) filings or national applications—guides the global strategic outlook, although the ‘978 Patent’ itself focuses solely on U.S. rights.


Implications for Industry Stakeholders

  • For Innovators: The broad scope presents opportunities to secure comprehensive protection across chemical variants and indications, solidifying market exclusivity.

  • For Competitors: They must carefully analyze the patent’s claims to design around or challenge its validity, especially where prior art overlaps.

  • For Patent Owners: Vigilance regarding potential infringement and strategic patent filing (e.g., follow-up applications) is crucial to maintaining competitive dominance.


Conclusion

The ‘978 Patent’ exemplifies a well-crafted chemical compound patent with robust composition and method claims aimed at securing a strategic market position within its therapeutic class. Its scope covers essential chemical derivatives and associated medical uses, reinforced through narrow dependent claims. Its landscape encompasses overlapping patents, prior art considerations, and potential litigations, emphasizing the importance of continuous patent landscape analysis for stakeholders.


Key Takeaways

  • The ‘978 Patent’ provides broad protection for a class of chemical compounds with specific therapeutic applications, making it a powerful asset for the patent holder.

  • Its claims are structured to cover both chemical compositions and methods, thereby broadening enforcement avenues and deterrents against generic competitors.

  • A critical analysis of prior art and strategic patent filings—such as continuations—are necessary to maintain a competitive advantage.

  • Competitors should analyze the patent’s scope for designing non-infringing alternatives or invalidating the patent through prior art disclosures.

  • Ongoing patent landscape monitoring is essential given emerging patents and possible litigation that could impact market exclusivity.


FAQs

1. What is the primary innovation claimed in U.S. Patent 7,146,978?
The patent claims novel chemical compounds characterized by a specific structural formula, along with methods of use for treating particular diseases, such as neurological disorders, with these compounds.

2. How broad are the claims in the ‘978 Patent’?
The claims generally encompass a class of derivatives based on a core chemical scaffold, with various substituents, and include therapeutic methods, enabling protection over a wide chemical space.

3. Can the ‘978 Patent’ be challenged based on prior art?
Yes. Validity challenges can be mounted if prior art discloses similar compounds, synthesis methods, or uses that anticipate or render the claims obvious.

4. Does the patent landscape include international counterparts?
While this patent specifically pertains to U.S. rights, related patents or equivalents may exist internationally, affecting global market strategies.

5. What are the strategic considerations for companies competing with this patent?
They should analyze claim scope carefully, identify potential designing-around strategies, evaluate prior art for invalidation opportunities, and consider filing their own patent applications to carve out specific niches.


Sources:

[1] USPTO Patent Database, U.S. Patent No. 7,146,978.
[2] Patent Analytics Reports, PatentScope, WIPO.
[3] Scientific Literature and Patent Literature relevant to chemical derivatives and therapeutic uses in the same class.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 7,146,978

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,146,978

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 316397 ⤷  Get Started Free
Austria 394136 ⤷  Get Started Free
Australia 2002255808 ⤷  Get Started Free
Australia 2002334929 ⤷  Get Started Free
Canada 2444129 ⤷  Get Started Free
Canada 2477653 ⤷  Get Started Free
Cyprus 1108214 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.